Radius Health Inc. (RDUS)

28.47
0.39 1.35
NASDAQ : Health Technology
Prev Close 28.86
Open 28.89
Day Low/High 27.75 / 29.33
52 Wk Low/High 12.81 / 29.97
Volume 1.74M
Avg Volume 496.90K
Exchange NASDAQ
Shares Outstanding 46.12M
Market Cap 1.32B
EPS -4.90
P/E Ratio N/A
Div & Yield N.A. (N.A)
Erytech Pharma Plummets on Phase 2 Data -- Biotech Movers

Erytech Pharma Plummets on Phase 2 Data -- Biotech Movers

France-based firm said its Phase 2 study of eryaspase (Graspa) in acute myeloid leukemia did not achieve its primary endpoint of overall survival.

First Week of December 15th Options Trading For Radius Health (RDUS)

First Week of December 15th Options Trading For Radius Health (RDUS)

Investors in Radius Health Inc saw new options begin trading this week, for the December 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the RDUS options chain for the new December 15th contracts and identified one put and one call contract of particular interest.

Radius Health Initiates Phase 1 Clinical Trial Of RAD140 For The Treatment Of Hormone Receptor Positive Breast Cancer

Radius Health Initiates Phase 1 Clinical Trial Of RAD140 For The Treatment Of Hormone Receptor Positive Breast Cancer

Study will evaluate safety, dose and tumor response in postmenopausal women with metastatic disease

Biotech Movers: NeuroDerm Shares Soar on Sale to Japanese Firm

Biotech Movers: NeuroDerm Shares Soar on Sale to Japanese Firm

NeuroDerm, Novavax and Nektar Therapeutics were among the biotech stock movers in premarket trading on July 24.

Radius Health Appoints Jesper Hoiland As President And Chief Executive Officer To Lead The Next Stage Of Growth And Value Creation As A Fully Integrated Commercial Biotech Company

Radius Health Appoints Jesper Hoiland As President And Chief Executive Officer To Lead The Next Stage Of Growth And Value Creation As A Fully Integrated Commercial Biotech Company

Mr. Hoiland brings unique experience in launching new products, creating growth strategies and leading high-performing organizations

Biotech Movers: BioCryst, Omeros, Radius Health

Biotech Movers: BioCryst, Omeros, Radius Health

BioCryst Pharmaceuticals, Omeros and Radius Health were among the were among the biotech stock movers in premarket trading on July 3.

First Week of RDUS August 18th Options Trading

Investors in Radius Health Inc saw new options become available this week, for the August 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the RDUS options chain for the new August 18th contracts and identified one put and one call contract of particular interest.

TheStreet Quant Rating: D- (Sell)